Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

Journal of Clinical Investigation

Volumn 98, Issue 7, 1996, Pages 1676-1683

  Akdis, Cezmi A ^a   Akdis, Mübeccel ^a   Blesken, Thorsten ^a   Wymann, Daniel ^a   Alkan, Sefik S ^b   Müller, Ulrich ^c   Blaser, Kurt ^a  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

^b CIBA GEIGY LTD   (Switzerland)

^c Spital Netz Bern   (Switzerland)

Author keywords

anti PLA IgE; anti PLA IgG4; bee venom allergy; interleukin 4; recovery from anergy; T cell anergy

Indexed keywords

BEE VENOM; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; PHOSPHOLIPASE A2;

ADULT; ARTICLE; BEE STING; CLINICAL ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; EPITOPE MAPPING; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INSECT ALLERGY; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029820287     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118963     Document Type: Article

References (65)

1. Reid, M.J., R.B. Moss, Y.P. Hsu, J.M. Kwasnicki, T.M. Commerford, and B.L. Nelson. 1986. Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy. J. Allergy Clin. Immunol. 78:590-600.
2. Hussain, R., R.W. Poindexter, and E.A. Ottesen. 1992. Control of allergic reactivity in human filariasis. Predominant localisation of blocking antibody to the IgG4 subclass. J. Immunol. 148:2731-2739.
3. 2. J. Immunol. 150:3582-3591.
4. Rocklin, R.E., A. Sheffer, D.K. Greineder, and K. L. Melmon. 1980. Generation of antigen-specific supressor cells during allergy desensitization. N. Engl. J. Med. 302:1213-1219.
5. Otsuka, H., A. Mezawa, M. Ohnishi, K. Okubo, H. Seki, and M. Okuda. 1991. Changes in nasal metachromatic cells during allergen immunotherapy. Clin. Exp. Allerg. 21:115-120.
6. Crecitos, P.S., N. Franklin Adkinson, Jr., A. Kagey-Sobotka, D. Proud, H.L. Meier, R.M. Naclerio, L.M. Lichtenstein, and P.S. Norman. 1983. Nasal challenge with ragweed in hay fever patients: Effect of immunotherapy. J. Clin. Invest. 76:2247-2253.
7. Furin, M.J., P.S. Norman, P.S. Creticos, D. Proud, A. Kagey-Sobotka, L.M. Lichtenstein, and R.M. Naclerio. 1991. Immunotherapy decreases antigen-induced eosinophil migration into the nasal cavity. J. Allergy Clin. Immunol. 88:27-32.
8. Rak, S., O. Rowhagen, and P. Venge. 1988. The effect of immunotherapy on bronchial hyper-responsiveness and eosinophil cationic protein in pollen allergic patients. J. Allergy Clin. Immunol. 82:470-480.
9. Del Prete, G., E. Maggi, P. Paola, I. Ghretien, A. Tiri, D. Macchia, J. Banchereau, J.E. De Vries, and S. Romagnani. 1988. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J. Immunol. 140:4193-4198.
10. Punnonen, J., G. Aversa, B.G. Cocks, A.N.J. Mc Kenzie, S. Menon, G. Zurawski, R. De Waal Melefyt, and J.E. De Vries. 1993. Interleukin-13 induces interleukin-4 independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA. 90:3730-3734.
11. Walker, C., J.C. Virchow, Jr., P.L.B. Bruijnzeel, and K. Blaser. 1991. T cell subsets and their soluble products regulate eosinophilia in allergic and non-allergic asthma. J. Immunol. 146:1829-1835.
12. Seminario, M.-C., and G.J. Gleich. 1994. The role of eosinophils in the pathogenesis of asthma. Curr. Opin. Immunol. 6:860-864.
13. + T cells. Immunol. Today. 12:392-395.
14. Robinson, D.S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A.M. Bentley, C. Corrigan, S.R. Durham, and A.B. Kay. 1992. Predominant Th2-like bronchoalveolar T lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
15. Secrist, H., C.J. Chelen, Y. Wen, J.D. Marshall, and D.T. Umetsu. 1993. Allergen immunotherapy decreases interleukin 4 production in CD4 T cells from allergic individuals. J. Exp. Med. 178:2123-2130.
16. Jutel, M., W.J. Pichler, D. Skrbic, A. Urwyler, C. Dahinden, and U.R. Muller. 1995. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen stimulated T cell cultures. J. Immunol. 154:4187-4194.
17. Kuchler, K., M. Gmachl, M.J. Sippl, and G. Kreil. 1989. Analysis of the cDNA for phospholipase A2 from honey bee venom glands. Eur. J. Biochem. 1184:249-254.
18. 2 from honey bee venom is similar. J. Allergy Clin. Immunol. 96:395-402.
19. Sobotka, A.K., R.M. Franklin, N.F. Adkinson Jr., M. Valentine, H. Bauer, and L.M. Lichtenstein. 1976. Allergy to insect sting II. Phospholipase A: the major allergen in honey bee venom. J. Allergy Clin. Immunol. 57:29-40.
20. Aalberse, R.C., R. van der Gaag, and J. van Leuwen. 1983. Serologic aspects of IgG4 antibodies. I. Prolonged immunisation results in an IgG4-restricted response. J. Immunol. 130:722-726.
21. Lucas, A.H. 1990. IgG subclass restricted immune responses to allergens. Semin. Immunopathol. 12:385-400.
22. Graft, D.F. 1987. Venom immunotherapy for stinging insect allergy. Clin. Rev. Allergy. 5:149-159.
23. Randolph, C.C., and R.E. Reisman.1986. Evaluation of decline in serum venom specific IgE as a criterion for stopping venom immunotherapy. J. Allergy Clin. Immunol. 77:823-827.
24. Ferrante, A., F. Mocatta, and D.H.B. Goh. 1986. Changes in IgG and IgE antibodies to bee venom during immunotherapy. Int. Arch. Allergy Appl. Immunol. 91:284-287.
25. Dudler, T., F. Altmann, J.M. Carballido, and K. Blaser. 1995. Carbohydrate dependent, HLA Class II-restricted, human T cell response to the bee venom allergen phospholipase A2 in allergic patients. Eur. J. Immunol. 25:538-542.
26. Mueller, H.L. 1966. Diagnosis and treatment of insect sensitivity. J. Asthma Res. 3:331-333.
27. Birnbaum, J., D, Charpin, and D. Vervloet. 1993. Rapid hymenoptera venom immuno-therapy: comparative safety of three protocols. Clin. and Exp. Allergy. 23:226-230.
28. Von Grüningen, R., and C.H. Schneider. 1989. Antigenic structure of the hexacosa-peptide mellitin: evidence for three determinants, one with a helical conformation. Immunology. 66:339-342.
29. Lane, P., T. Brocker, S. Hubele, E. Padovan, A. Lanzavecchia, and F.F. Mc Connell. 1993. Soluble CD40 ligand can replace the normal T cell derived CD40 ligand signal to B cells in T cell-dependent activation. J. Exp. Med. 177: 1209-1213.
30. Alkan, S., C. Akdis, and H. Towbin. 1994 Chemiluminescent and enzyme-linked immuno assays for sensitive detection of human IFN-γ. J. Immuno. Assay. 15:217-238.
31. Weeks, I., and J.S. Woodhead. 1984. Chemiluminescence Immunoassay. J. Clin. Immunoassay. 7:82-89.
32. Gillis, S., M.M. Ferm, W. Ou, and K.A. Smith. 1978. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120:2027-2032.
33. 2-specific human IgE and IgG4 antibodies in vitro requires specific and non-specific activation of T and B cells. J. Allergy Clin. Immunol. In -press.
34. Held, W., M. Stucki, C.H. Heusser, and K. Blaser. 1989. Production of human antibodies to bee venom phospholipase A2 in vitro. Scand. J. Immunol. 29:203-209.
35. Rieben, R., and K. Blaser. 1989 Quantification of IgG and IgG4 antibodies to bee venom phospholipase A2 by inhibition ELISA. J. Immunol. Methods. 119:1-8.
36. 2 in vitro. J. Allergy Clin. Immunol. 93:758-767.
37. 2. J. Allergy Clin. Immunol. 94:61-69.
38. Greenstein, J.L., J.P. Morgenstern, J. LaRaia, C.M. Counsell, W.H. Goodwin, A. Lussier, P.S. Creticos, P.S. Norman, and R.D. Garman. 1992. Ragweed immunotherapy decreases T cell reactivity to recombinant Amb a 1.1. J. Allergy Clin. Immunol. 89:322. (Abstr.)
39. Creticos, P.S. 1992. Immunologic changes associated with immunotherapy. In Immunology and Allergy Clinics of North America: Immunotherapy of IgE mediated disorders. P.A. Greenberger, editor. WB Saunders, Philadelphia. 13-37.
40. Varney, V.A., Q.A. Hamid, M. Gaga, S. Ying, M. Jacobson, A.J. Frew, A.B. Kay, and S.R. Durham 1993. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J. Clin. Invest. 92:644-651.
41. Nossal, G.J.V., and B.L. Pike. 1980. Clonal anergy: persistance in tolerant mice of antigen-binding B lymphocytes incapable of responding to antigen or mitogen. Proc. Natl. Acad. Sci. USA. 77:1602-1606.
42. Schwartz, R.H. 1990. A cell culture model for T lymphocyte clonal anergy. Science (Wash. DC). 248:1349-1356.
43. Miller, A., O. Lider, and H.L. Weiner. 1991. Antigen-driven bystander suppression after oral administration of antigen. J. Exp. Med. 174:791-798.
44. Murphy, D.B. 1993. T cell mediated immunosuppression. Curr. Opin. Immunol. 5:411-417.
45. Müller D.L., M.K. Jenkins, and R.H. Schwartz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445-480.
46. Gammon, G., N. Shastri, and J. Cogswell. 1987. The choice of T cell epitopes utilized on a protein antigen depends on multiple factors distant from as well as the determinant site. Immunol. Rev. 98:53-73.
47. Ria, F., B.M.C. Chan, M.T. Schere, J.A. Smith, and M.L. Gefter. 1990. Immunological activity of covalently linked T cell epitopes. Nature (Lond.). 343:381-383.
48. Gammon, G., E.E. Sercarz, and G. Benichou. 1991. The dominant self and the cryptic self; shaping the autoreactive T cell repertoire. Immunol. Today. 12:193-195.
49. Burstein, H.J., C.M. Shea, and A.K. Abbas. 1992. Aqueous antigens induce in vivo tolerance selectively in IL-2 and IFN-γ producing (Th1) cells. J. Immunol. 148:3687-3691.
50. Gahring, L.C., and W.O. Wiegle. 1989. The induction of peripheral T cell unresponsiveness in adult mice by monomeric γ globulin. J. Immunol. 143: 2094-2100.
51. Lamb, J.R., B.J. Skidmore, N. Green, J.M. Chiller, and M. Feldman. 1983. Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J. Exp. Med. 157:1434-1447.
52. Hoyne, G.F., R.E. O'Hehir, D.C. Wraith, W.R. Thomas, and J.R. Lamb. 1993. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J. Exp. Med. 178:1783-1788.
53. Essery, G., M. Feldmann, and J. Lamb. 1988. Interleukin-2 can prevent and reverse antigen-induced unresponsiveness in cloned human T lymphocytes. Immunology. 64:413-417.
54. c chain of IL-2 receptor. Science (Wash. DC). 266:1039-1042.
55. Gilbert, K.M., K.D. Hoang, and W.O. Weigle. 1990. Th1 and Th2 clones differ in their response to a tolerogenic signal. J. Immunol. 144:2063-2069.
56. Fasler, S., G. Aversa, A. Terr, K. Thestrup-Pedersen, J.E. de Vries, and H. Yssel. 1995. Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. J. Immunol. 155:4199-4206.
57. Nguyen, D.D., L. Beck, and H.L. Spiegelberg. 1995. Anti-CD3 induced anergy in cloned human Th0, Th1 and Th2 cells. Cell Immunol. 165:153-157.
58. Grabstein, K.H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M.A. Schoenborn, M. Ahdieh, L. Johnson, M.R. Anderson, J.D. Watson, D.M. Anderson, and J.G. Giri. 1994. Cloning of a T cell growth factor which interacts with the β chain of interleukin-2 receptor. Science (Wash. DC). 264:965-968.
59. Armitage, R.J., B.M. Macduff, J. Eisenman, R. Paxton, and K.H. Grabstein. 1995. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol. 154:483-490.
60. Lockey R., P. Turkeltaub, E. Olive, J. Hubbard, I. Baird-Warren, and S. Bukantz. 1990. The Hympenoptera venom study III: Safety of venom immunotherapy. J. Allergy Clin. Immunol. 86:775-780.
61. Carballido, J.M., N. Carballido-Perrig, G. Terres, C.H. Heusser, and K. Blaser. 1992. Bee venom phospholipase A2 specific T-cell clones from human allergic and non allergic individuals: cytokine patterns change in response to antigen concentration. Eur. J. Immunol. 22:1357-1363.
62. Müller, U., A. Helbling, and M. Bischof. 1989. Predictive value of venom specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom. Allergy. 44:412-418.
63. 2. Proc. Natl. Acad. Sci. USA. 85:6880-6884.
64. + T cell clones and IL-4 induce IgG4 and IgE switching in purified B cells via different signalling pathways. J. Immunol. 147:8-13.
65. Mosmann, T.R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 17:142-146.